What is HTG Molecular Diagnostics 12-1 Month Momentum %?
12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-05-03), HTG Molecular Diagnostics's 12-1 Month Momentum % is -99.94%.
The industry rank for HTG Molecular Diagnostics's 12-1 Month Momentum % or its related term are showing as below:
HTGMQ's 12-1 Month Momentum % is not ranked
in the Medical Diagnostics & Research industry.
Industry Median: -19.83
vs HTGMQ: -99.94
Competitive Comparison of HTG Molecular Diagnostics's 12-1 Month Momentum %
For the Diagnostics & Research subindustry, HTG Molecular Diagnostics's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HTG Molecular Diagnostics's 12-1 Month Momentum % Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, HTG Molecular Diagnostics's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where HTG Molecular Diagnostics's 12-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
HTG Molecular Diagnostics 12-1 Month Momentum % Related Terms
Thank you for viewing the detailed overview of HTG Molecular Diagnostics's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.
HTG Molecular Diagnostics (HTG Molecular Diagnostics) Business Description
HTG Molecular Diagnostics Inc is a commercial-stage RNA platform-based life sciences company focused on advancing the promise of precision medicine. Its proprietary NGS-adapted chemistry and HTG EdgeSeq platform automates sample processing and can quickly, robustly, and simultaneously profile hundreds or thousands of molecular targets using a relatively small amount of biological samples, in liquid or solid forms. Its products include instruments, consumables, and software that combine to form its HTG EdgeSeq platform. The company's menu of HTG EdgeSeq molecular profiling panels is automated on its HTG EdgeSeq platform, applying genomic sequencing tools to quickly generate gene expression data using its simplified workflow for customers.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HTGMQ has been successfully added to your